BioRestorative Therapies, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-021993
- Form type
- 10-Q
- CIK
- 0001505497
- Primary document
- https://www.sec.gov/Archives/edgar/data/1505497/000149315225021993/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioRestorative Therapies, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $340,100 | - | - |
| Cost Of Revenue | $22,208 | - | - |
| Gross Profit | $317,892 | - | - |
| Operating Income | $-11.8M | - | - |
| Net Income | $-11.0M | - | - |
| Eps Basic | -1.26 | - | - |
| Eps Diluted | -1.26 | - | - |
| Cash And Equivalents | $602,444 | - | - |
| Total Assets | $5.6M | - | - |
| Shareholders Equity | $2.2M | - | - |
| Operating Cash Flow | $-8.4M | - | - |
| Capital Expenditures | $36,400 | - | - |